Autoimmune hypothyroidism and granulocyte-macrophage colony-stimulating factor.
Hansen
P B
PB
Johnsen
H E
HE
Hippe
E
E
D015250:Aclarubicin / Q000008:administration & dosage; D000208:Acute Disease; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols; D001327:Autoimmune Diseases / Q000097:blood / Q000209:etiology*; D003561:Cytarabine / Q000008:administration & dosage; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007037:Hypothyroidism / Q000097:blood / Q000209:etiology* / Q000276:immunology; D007453:Iodide Peroxidase / Q000276:immunology; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008297:Male; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D013960:Thyroid Function Tests; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
D011994:Recombinant Proteins; D003561:Cytarabine; D014284:Triiodothyronine; D015250:Aclarubicin; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D013972:Thyrotropin; D007453:Iodide Peroxidase; D013974:Thyroxine